Regenerative treatment for ALS utilizes stem cell therapy or exosome therapy to slow the progression of neurodegeneration, promote motor neuron repair, and improve quality of life for individuals with amyotrophic lateral sclerosis (ALS).
Regenerative treatment for ALS (amyotrophic lateral sclerosis) focuses on slowing the progression of this neurodegenerative disease through the use of stem cell therapy or exosome therapy. These treatments aim to repair damaged motor neurons, reduce inflammation in the central nervous system, and promote neurogenesis (the growth of new neurons), potentially improving motor function and overall quality of life for individuals with ALS. While these therapies are still considered investigational, they offer a hopeful avenue for treating ALS, addressing its underlying biological factors rather than just the symptoms. Both stem cell and exosome therapies are minimally invasive, with the potential to delay the onset of severe symptoms and enhance the patient's day-to-day abilities.